Assessment of methods used to determine the safety of the topical insect repellent N,N-diethyl-m-toluamide (DEET)

Article English OPEN
Chen-Hussey, Vanessa ; Behrens, Ron ; Logan, James G (2014)
  • Publisher: Springer Nature
  • Journal: Parasites & Vectors, volume 7, pages 173-173 (eissn: 1756-3305)
  • Related identifiers: doi: 10.1186/1756-3305-7-173, pmc: PMC4041896
  • Subject: Toxicity | N,N-diethyl-m-toluamide, Insect repellents, Safety | Review | Infectious Diseases | Parasitology

N,N-diethyl-m-toluamide (DEET) has been registered for commercial use as an insect repellent for over five decades,\ud and is used widely across the world. Concerns over the safety of DEET first emerged during the 1980s after reports\ud of encephalopathy following DEET exposure, particularly in children. However, the role of DEET in either the illness\ud or deaths was and remains purely speculative. In response to these cases a number of reviews and investigations of\ud DEET safety were carried out. Here we examine the methods used and information available to determine the\ud safety of DEET in humans. Animal testing, observational studies and intervention trials have found no evidence of\ud severe adverse events associated with recommended DEET use. Minor adverse effects noted in animal trials were\ud associated with very large doses and were not replicated between different test species. The safety surveillance\ud from extensive humans use reveals no association with severe adverse events. This review compares the toxicity\ud assessment using three different models to define the risk assessment and safety threshold for DEET use in humans\ud and discusses the clinical consequences of the thresholds derived from the models.\ud The theoretical risks associated with wearing an insect repellent should be weighed against the reduction or\ud prevention of the risk of fatal or debilitating diseases including malaria, dengue, yellow fever and filariasis. With over\ud 48 million European residents travelling to regions where vector borne diseases are a threat in 2009, restricting the\ud concentration of DEET containing repellents to 15% or less, as modelled in the 2010 EU directive, is likely to result\ud in extensive sub-therapeutic activity where repellents are infrequently applied. Future European travellers, as a\ud consequence of inadequate personal protection, could potentially be at increased risk of vector borne diseases. Risk\ud assessments of repellents should take these factors into account when setting safe limits.
  • References (43)
    43 references, page 1 of 5

    1. Nentwig G: Use of repellents as prophylactic agents. Parasitol Res 2003, 90(Suppl 1):S40-S48.

    2. Barnard DR: Repellents and Toxicants for Personal Protection. Position Paper. Global Collaboration for Development of Pesticides for Public Health. Geneva, Switzerland: World Health Organization; 2000 [Global Collaboration for Development of Pesticides for Public Health (Series editor)].

    3. U.S. Environmental Protection Agency: Insect Repellent Product Labeling Consumer Survey Report. Washington DC, USA: US Environmental Protection Agency Office of Pesticide Programs; 2012.

    4. Kline & Company: Consumer Markets for Pesticides and Fertilizers USA. Parsippany, USA: Kline & Company, Incorporated; 2004.

    5. Goodyer LI, Croft AM, Frances SP, Hill N, Moore SJ, Onyango SP, Debboun M: Expert review of the evidence base for arthropod bite avoidance. J Travel Med 2010, 17:182-192.

    6. WHO: Guidelines for Efficacy Testing of Mosquito Repellents for Human Skin. Geneva, Switzerland: Control of Neglected Tropical Diseases and WHO Pesticide Evaluation Scheme; 2009.

    7. Tawatsin A, Thavara U, Chansang U, Chavalittumrong P, Boonruad T, Wongsinkongman P, Bansidhi J, Mulla MS: Field evaluation of deet, Repel Care, and three plant based essential oil repellents against mosquitoes, black flies (Diptera: Simuliidae) and land leeches (Arhynchobdellida: Haemadipsidae) in Thailand. J Am Mosq Control Assoc 2006, 22:306-313.

    8. Robbins PJ, Cherniak MG: Review of the biodistribution and toxicity of the insect repellent N, N-diethyl-m-toluamide (DEET). J Toxicol Environ Health 1986, 18:503-525.

    9. Osimitz TG, Murphy JV, Fell LA, Page B: Adverse events associated with the use of insect repellents containing N, N-diethyl-m-toluamide (DEET). Regul Toxicol Pharmacol 2010, 56:93-99.

    10. World Health Organization International Programme on Chemical Safety: Principles for the Assessment of Risks to Human Health from Exposure to Chemicals. Geneva: World Health Organization; 1999.

  • Metrics
    No metrics available
Share - Bookmark